MedTech Acquisition Corporation (MTACW) Stock
MTACW is a publicly listed Shell Companies company in the Financial Services sector, traded on US stock exchanges.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About MedTech Acquisition Corporation
MTACW is a publicly listed Shell Companies company in the Financial Services sector, traded on US stock exchanges.
the stock is valued at a negative price-to-earnings (P/E) ratio of -0.12, reflecting a net loss over the last twelve months, price-to-book of 1.83, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.01 and $0.25, and currently trades 12.0% below its 52-week high.
On profitability, MedTech Acquisition Corporation generates a return on equity (ROE) of 114.71% (not meaningful, as shareholders' equity is negative), return on capital employed of -59.50%, an operating margin of -60.00%, a net profit margin of -86.67%.
Related Financial Services Stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.